Inspiring female healthcare scientists awarded

pharmafield logo - pharma news

Four of the country’s finest female scientists have won the first Chief Scientific Officer’s (CSO) Women in Science and Engineering (WISE) Fellowship scheme, NHS England has announced.

The competition, launched in conjunction with international women’s day in March 2016, recieved 60 applicants from female healthcare scientists who will now act as role models to inspire the next generation of female scientists.

The Chief Scientific Officer’s WISE Fellowship Programme is a bespoke 12 month initiative, launched in partnership with WISE – the campaign to promote women in science, technology and engineering.

The winners are:

 

  • Dr Kathryn Harris, Clinical Scientist, Microbiology, Great Ormond Street Hospital for Children, NHS Foundation Trust
  • Ms Sandra Chinyere, Clinical Service Manager, Neurophysiology, Ashford & St. Peter’s Hospitals NHS Foundation Trust
  • Mrs Michelle Martin, Training Manager, Senior Specialist Biomedical Scientist, Haematology and Blood Transfusion, Barts Health NHS Trust
  • Dr Charlotte Kemp, Head of Clinical Measurement, Consultant Clinical Scientist, South Tees Hospitals NHS Foundation Trust.

 

The scheme received such a high quality of applications that an additional one day leadership development opportunity will also be open to all applicants.

Starting in September 2016, the Fellowship will offer a career development programme, providing mentoring support, communication and leadership skills training. In addition to allocated training, activity and network days, the fellows will attend both the WISE and Chief Scientific Officer conferences later in the year.

Professor Sue Hill OBE, Chief Scientific Officer for England, said: “We have been working with WISE to create this unique fellowship scheme and support the aim of getting one million more women working in the UK science, technology, engineering and maths (STEM) workforce. The NHS Constitution makes it clear that a central principle of the health service is that it ‘operates at the limits of science’.”